Key result
High serum phosphorus levels (>1.95 mmol/L) were independently associated with a more than fivefold increased odds of left ventricular diastolic dysfunction (OR 5.24) compared to levels <1.34 mmol/L in peritoneal dialysis patients.
Why the study?
Is high serum phosphorus level associated with left ventricular diastolic dysfunction in peritoneal dialysis patients?
Observational (n=174)
No
Is high serum phosphorus level associated with left ventricular diastolic dysfunction in peritoneal dialysis patients?
High serum phosphorus levels are independently associated with an increased risk of left ventricular diastolic dysfunction in patients on peritoneal dialysis.
High phosphorus associated with LVDD in PD; hypothesis-generating, should not yet change practice.
OBJECTIVES: We initiated this study to explore the relationships of serum phosphorus level with left ventricular ultrasound features and diastolic function in peritoneal dialysis (PD) patients. METHODS: 174 patients with end-stage renal disease (ESRD) receiving PD were enrolled in this retrospective observational study. Conventional echocardiography examination and tissue Doppler imaging (TDI) were performed in each patient. Clinical information and laboratory data were also collected. Analyses of echocardiographic features were performed according to phosphorus quartiles groups. And multivariate regression models were used to determine the association between serum phosphorus and Left ventricular diastolic dysfunction (LVDD). RESULTS: With the increase of serum phosphorus levels, patients on PD showed an increased tissue Doppler-derived E/e' ratio of lateral wall (P < 0.001), indicating a deterioration of left ventricular diastolic function. Steady growths of left atrium and left ventricular diameters as well as increase of left ventricular muscle mass were also observed across the increasing quartiles of phosphorus, while left ventricular ejection fraction remained normal. In a multivariate analysis, the regression coefficient for E/e' ratio in the highest phosphorus quartile was almost threefold higher relative to those in the lowest quartile group. And compared with patients in the lowest phosphorus quartile (<1.34 mmol/L) those in the highest phosphorus quartile (>1.95 mmol/L) had a more than fivefold increased odds of E/e' ratio >15. CONCLUSIONS: Our study showed an early impairment of left ventricular diastolic function in peritoneal dialysis patients. High serum phosphorus level was independently associated with greater risk of LVDD in these patients. Whether serum phosphorus will be a useful target for prevention or improvement of LVDD remains to be proved by further studies.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2016) conducted an observational in End-stage renal disease on peritoneal dialysis (n=174). High serum phosphorus level (>1.95 mmol/L) vs. Low serum phosphorus level (<1.34 mmol/L) was evaluated on Left ventricular diastolic dysfunction (E/e' ratio >15) (OR 5.24, 95% CI 1.34-20.45, p=0.008). High serum phosphorus levels (>1.95 mmol/L) were independently associated with a more than fivefold increased odds of left ventricular diastolic dysfunction (OR 5.24) compared to levels <1.34 mmol/L in peritoneal dialysis patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: